Hu Y W, Balaskas E, Furione M, Yen P H, Kessler G, Scalia V, Chui L, Sher G
Canadian Blood Services, Ottawa, Ontario, Canada K1G 4J5.
J Clin Microbiol. 2000 Aug;38(8):2807-13. doi: 10.1128/JCM.38.8.2807-2813.2000.
To date the true prevalence of hepatitis C virus (HCV) mixed-genotype infections has not been established mainly because currently available methods are not suitable for the detection of mixed genotypes in a viral population. A novel semiautomated genotyping method, primer-specific and mispair extension analysis (S-PSMEA), which is more reliable than other genotyping assays was developed for detection of HCV mixed-genotype infections. A genotype present at levels as low as 0.8% in a defined mix of HCV genotypes was detected, showing a 20-fold increase in sensitivity over that of direct DNA sequencing. A total of 434 HCV isolates were genotyped and analyzed for a comparative study of the accuracy between S-PSMEA and four current genotyping methods. The results showed that viruses in approximately 40% of the samples from this group determined to be infected with mixed genotypes by S-PSMEA were undetected by direct DNA sequencing due to its low sensitivity. Type-specific PCR, line probe assay, and restriction fragment length polymorphism analysis performed poorly, being able to identify only 38.5, 16.1, and 15.4% of mixed-genotype infections, respectively, that were detected by direct DNA sequencing. The prevalence of mixed-genotype infections detected by S-PSMEA was 7.9% (12 of 152 donors) among HCV-infected blood donors, 14.3% (15 of 105) among patients with chronic hepatitis C, and 17.1% (6 of 36) among thalassemia patients who had received multiple transfusions. The data lead us to conclude that HCV mixed-genotype infections are more common than previously estimated and that S-PSMEA may be the method of choice when detection of genotypes present at low levels in mixed-genotype infections is required due to its higher level of sensitivity.
迄今为止,丙型肝炎病毒(HCV)混合基因型感染的真实流行率尚未确定,主要原因是目前可用的方法不适用于检测病毒群体中的混合基因型。一种新型的半自动化基因分型方法,即引物特异性错配延伸分析(S-PSMEA)被开发出来用于检测HCV混合基因型感染,该方法比其他基因分型检测更可靠。在定义的HCV基因型混合物中,低至0.8%水平的基因型也能被检测到,其灵敏度比直接DNA测序提高了20倍。总共对434株HCV分离株进行了基因分型,并分析了S-PSMEA与四种当前基因分型方法之间准确性的比较研究。结果表明,由于直接DNA测序灵敏度低,在该组中约40%被S-PSMEA确定为感染混合基因型的样本中的病毒未被检测到。型特异性PCR、线性探针分析和限制性片段长度多态性分析表现不佳,分别只能识别直接DNA测序检测到的混合基因型感染的38.5%、16.1%和15.4%。在HCV感染的献血者中,S-PSMEA检测到的混合基因型感染率为7.9%(152名献血者中有12名),慢性丙型肝炎患者中为14.3%(105名中有15名),接受多次输血的地中海贫血患者中为17.1%(36名中有6名)。这些数据使我们得出结论,HCV混合基因型感染比以前估计的更常见,并且由于S-PSMEA具有更高的灵敏度,当需要检测混合基因型感染中低水平存在的基因型时,它可能是首选方法。